Development and validation of a rapid HPLC method for the simultaneous determination of triethylenetetramine and its two main metabolites in human serum

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 860, Issue 1, 2007, Pages 42-48

  Othman, Asma ^a,b   Lu, Jun ^a   Sunderland, Tracey ^a   Cooper, Garth J S ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Diabetic heart failure; FMOC; HPLC; LC MS; TETA

Indexed keywords

DIABETIC HEART FAILURE; HUMAN SERUM;

BODY FLUIDS; DRUG PRODUCTS; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

AMINES;

DRUG METABOLITE; N1 ACETYLTRIETHYLENETETRAMINE; N1,N10 DIACETYLTRIETHYLENETETRAMINE; TRIENTINE; TRIENTINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; DEVELOPMENT; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE; VALIDITY; VOLUNTEER;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIETHYLENETETRAMINE;

EID: 36349023417     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.10.006     Document Type: Article

References (12)

1. Walshe J.M. Lancet 1 (1982) 643
2. Cooper G.J., Phillips A.R., Choong S.Y., Leonard B.L., Crossman D.J., Brunton D.H., Saafi L., Dissanayake A.M., Cowan B.R., Young A.A., Occleshaw C.J., Chan Y.K., Leahy F.E., Keogh G.F., Gamble G.D., Allen G.R., Pope A.J., Boyd P.D., Poppitt S.D., Borg T.K., Doughty R.N., and Baker J.R. Diabetes 53 (2004) 2501
3. Cooper G.J., Chan Y.K., Dissanayake A.M., Leahy F.E., Keogh G.F., Frampton C.M., Gamble G.D., Brunton D.H., Baker J.R., and Poppitt S.D. Diabetes 54 (2005) 1468
4. Gong D., Lu J., Chen X., Choong S.Y., Zhang S., Chan Y.-K., Glyn-Jones S., Gamble G.D., Phillips A.R., and Cooper G.J. Mol. Pharmacol. 70 (2006) 2045
5. Lu J., Chan Y.-K., Gamble G.D., Poppitt S.D., and Cooper G.J.S. Drug Metab. Dispos. 35 (2007) 221
6. Kodama H., Murata Y., Iitsuka T., and Abe T. Life Sci. 61 (1997) 899
7. Hansen Jr. E.B., Rushing L.G., and Thompson Jr. H.C. J. Anal. Toxicol. 9 (1985) 167
8. Kodama H., Meguro Y., Tsunakawa A., Nakazato Y., Abe T., and Murakita H. Tohoku J. Exp. Med. 169 (1993) 59
9. Miyazaki K., Kishino S., Kobayashi M., Arashima S., Matsumoto S., and Arita T. Chem. Pharm. Bull. 38 (1990) 1035
10. Nakano Y., Nohta H., Yoshida H., Saita T., Fujito H., Mori M., and Yamaguchi M. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 774 (2002) 165
11. Nohta H., Satozono H., Koiso K., Yoshida H., Ishida J., and Yamaguchi M. Analyt. Chem. 72 (2000) 4199
12. FDA, Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration, 2001.